Create a free ProFood World account to continue reading

Patheon & IMA Active: Advancing High-potency Solid Dose Manufacturing through Technology, Reliability and Strategic Partnership

Patheon details how IMA's blending, granulation, washing, and handling technologies contribute to efficient, high-containment manufacturing of oral solid dose products.

Originally established in 1993 and acquired by Thermo Fisher Scientific in 2017, Patheon is today one of the best recognised global CDMOs, supporting pharmaceutical companies in bringing high‑quality medicines to patients worldwide. Thermo Fisher’s mission, “to enable our customers to make the world healthier, cleaner and safer”, lies at the core of Patheon’s operations and strategic vision.

With manufacturing sites across Canada, the United States, Puerto Rico, Europe, Japan and Australia, Patheon offers end‑to‑end solutions that include formulation development, clinical supply, commercial manufacturing, packaging and logistics.

Fill out the form below to request more information about Patheon & IMA Active: Advancing High-potency Solid Dose Manufacturing through Technology, Reliability and Strategic Partnership
The building envelope is a production asset
Condensation, energy loss, and sanitation failures often trace back to the same place. This free article shows where to look.
Read More
The building envelope is a production asset